仙乐健康：副总经理、代理财务负责人郑丽群增持14万股

Core Viewpoint - Xianle Health announced that its Vice General Manager and Acting Financial Officer, Zheng Liqun, increased her stake in the company, reflecting confidence in its future development and long-term investment value [1] Group 1: Shareholding Activity - Zheng Liqun purchased 140,000 shares of Xianle Health on September 8, 2025, using her own funds through a block trading system [1] - This acquisition represents approximately 0.05% of the company's total share capital, which is about 306 million shares after excluding shares in the company's repurchase account [1] Group 2: Financial Performance - For the first half of 2025, Xianle Health's revenue composition was as follows: soft capsules accounted for 46.38%, gummies for 25.31%, tablets for 9.26%, functional beverages for 5.42%, and hard capsules for 5.31% [1] - As of the report date, Xianle Health's market capitalization was 7.7 billion yuan [1]